RISK OF HEPATOCELLULAR CANCER AFTER VIROLOGICAL CURE WITH DIRECT ACTING ANTIVIRAL AGENTS IN INDIVIDUALS WITH HEPATITIS C
$1,130,630FY2019Defense Health AgencyDOD
Baylor College Of Medicine, Houston TX
Investigators
View source on USAspending →RISK OF HEPATOCELLULAR CANCER AFTER VIROLOGICAL CURE WITH DIRECT ACTING ANTIVIRAL AGENTS IN INDIVIDUALS WITH HEPATITIS C · GrantIndex